Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma
Arch. endocrinol. metab. (Online)
; 59(2): 186-189, 04/2015. tab, graf
Article
en En
| LILACS
| ID: lil-746471
Biblioteca responsable:
BR1.1
ABSTRACT
Malignant insulinomas are frequently diagnosed at a late stage. Medical management is necessary to slow progression of the disease and control of hypoglycemic symptoms when cure by surgical treatment is not possible. Multimodal treatment, in these cases, has been used with variable clinical response. We describe a 68-yr-old woman who presented response failure to usual treatment and was alternatively treated with radiolabeled metaiodobenzylguanidine ([131I]-MIBG) analogue therapy with development of neurologic complications. We also present a review of the current role of [131I]-MIBG treatment in insulinomas.
Texto completo:
1
Índice:
LILACS
Asunto principal:
Neoplasias Pancreáticas
/
Compresión de la Médula Espinal
/
Radiofármacos
/
Insulinoma
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
Arch. endocrinol. metab. (Online)
Asunto de la revista:
ENDOCRINOLOGIA
/
METABOLISMO
Año:
2015
Tipo del documento:
Article